<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">248634</article-id><article-id pub-id-type="doi">10.18565/aig.2020-1.40-46</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">MicroRNAs and premature ovarian insufficiency</article-title><trans-title-group xml:lang="ru"><trans-title>МикроРНК и преждевременная овариальная недостаточность</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dmitrieva</surname><given-names>Margarita L.</given-names></name><name xml:lang="ru"><surname>Дмитриева</surname><given-names>Маргарита Леонидовна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Assistant of the Department of Obstetrics and Gynecology</p></bio><bio xml:lang="ru"><p>к.м.н., ассистент кафедры акушерства гинекологии</p></bio><email>margarita0708@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tikhonovskaya</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Тихоновская</surname><given-names>Ольга Анатольевна</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Professor of the Department of Obstetrics and Gynecology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры акушерства и гинекологии</p></bio><email>tikhonovskaya2012@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Romanova</surname><given-names>Anastasia A.</given-names></name><name xml:lang="ru"><surname>Романова</surname><given-names>Анастасия Александровна</given-names></name></name-alternatives><bio xml:lang="en"><p>student of the 2nd course of the Faculty of Medicine.</p></bio><bio xml:lang="ru"><p>студент 3 курса лечебного факультета</p></bio><email>doch.aleksandraromanova@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Logvinov</surname><given-names>Sergey V.</given-names></name><name xml:lang="ru"><surname>Логвинов</surname><given-names>Сергей Валентинович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Professor, Head of the Department of Histology, Embryology and Cytology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, зав. кафедрой гистологии, эмбриологии и цитологии, проректор по учебной работе</p></bio><email>s_logvinov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Siberian State Medical University Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Сибирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2020</year></pub-date><issue>1</issue><issue-title xml:lang="en">NO1 (2020)</issue-title><issue-title xml:lang="ru">№1 (2020)</issue-title><fpage>40</fpage><lpage>46</lpage><history><date date-type="received" iso-8601-date="2023-02-18"><day>18</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО «Бионика Медиа»</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/248634">https://journals.eco-vector.com/0300-9092/article/view/248634</self-uri><abstract xml:lang="en"><p>The relevance of studying the role of microRNAs in the pathogenesis of diseases of organs and systems is beyond question. The reproductive system is no exception. Since the early 2000s, many studies have been conducted to identify microRNAs in the ovaries. A literature review demonstrates the important role of microRNAs in folliculogenesis, including as regulators of apoptosis of granulosa cells, ovulation, and luteinization. It is established that microRNAs can be important regulatory molecules directly involved in premature ovarian insufficiency and polycystic ovary syndrome. MicroRNAs can become biological markers of ovarian reserve, which is of great importance in reproductology.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность изучения роли микроРНК в патогенезе заболеваний органов и систем не вызывает сомнения. Репродуктивная система не является исключением. С начала 2000-х гг. было проведено множество исследований по выявлению микроРНК в яичниках. Обзор литературы демонстрирует важную роль микроРНК в фолликулогенезе, в том числе в качестве регуляторов апоптоза в клетках гранулезы, при овуляции и лютеинизации. Установлено, что микроРНК могут быть важными регуляторными молекулами, участвующими непосредственно в формировании преждевременной овариальной недостаточности и синдрома поликистозных яичников. МикроРНК могут стать биологическими маркерами овариального резерва, что имеет большое значение в репродуктологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>microRNAs</kwd><kwd>ovary</kwd><kwd>reproduction</kwd><kwd>folliculogenesis</kwd><kwd>ovarian insufficiency</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>микроРНК</kwd><kwd>яичник</kwd><kwd>репродукция</kwd><kwd>фолликулогенез</kwd><kwd>овариальная недостаточность</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Герштейн Е.С., Кушлинский Д.Н., Адамян Л.В., и соавт. МикроРНК как биологические маркеры рака яичников. Молекулярная медицина. 2016; 14 (5): 3-14.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Chapman C., Cree L., Shelling A.N. The genetic of premature ovarian failure: current perspectives. Int J Womans Health. 2015; 7: 799-810. doi: 10.2147/IJWH.S64024.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Jiao X., Ke H, Qin Y., Chen Z.J. Molecular Genetics of Premature Ovarian Insufficiency. 2018; 29(11): 795-807. doi: 10.1016/j.tem.2018.07.002</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cordts E, Christofolini D, Amaro dos Santos A., et al. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011; 283: 635-43. doi: 10.1007/s00404-010-1815-4.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wood M.A., Rajkovic A. Genomic markers of ovarian reserve. Semin Reprod Med. 2013; 31: 399-415. doi: 10.1055/s-0033-1356476.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Qin Y., Jiao X., Dalgleish R., et al. Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure. Fertil Steril. 2014; 101(4): 1104-1109.e6. doi: 10.1016/j.fertnstert.2014.01.001.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Qin Y., Choi Y., Zhao H., Simpson J.L., Chen Z.J., Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet. 2007; 81: 576-581. doi: 10.1086/519496</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Lourenco D., Brauner R., Lin L., et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009; 360: 1200-10. doi: 10.1056/NEJMoa0806228.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Persani L., Rossetti R., Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010; 45: 257-79. doi: 10.1677/ JME-10-0070.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bashamboo A., McElreavey K. NR5A1/SF-1 and development and function of the ovary. Ann Endocrinol (Paris) 2010; 71: 177-82. doi: 10.1016/j.ando.2010.02.013.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rajkovic A., Pangas S.A., Ballow D., Suzumori N., Matzuk M.M. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004; 305: 1157-9. doi: 10.1126/science.1099755.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhao H., Chen Z.J., Qin Y., et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008; 82: 1342-8. doi: 10.1016/j.ajhg.2008.04.018.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Harris S., Chand A., Winship I., Gersak K., Aittomaki K., Shelling A. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002; 8: 729-33. doi: 10.1093/molehr/8.8.729</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Choi Y., Yuan D., Rajkovic A. Germ cell-specific transcriptional regulator Sohlh2 is essential for early mouse folliculogenesis and oocyte-specific gene expression. Biol Reprod. 2008; 79(6): 1176-82. doi: 10.1095/biolreprod.108.071217.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhao H., Li G., Dalgleish R., et al. Transcription factor SOHLH1 potentially associated with primary ovarian insufficiency. Fertil Steril. 2015; 103(2): 548-53.e5. doi: 10.1016/j.fertnstert.2014.11.011.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Tiotiu D., Alvaro Mercadal B., Imbert R., et al. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod. 2010; 25(6): 1581-7. doi: 10.1093/humrep/deq073.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chand A.L., Ponnampolam A., Harris S.E., et al. Mutational analysis of GDF9 and BMP15 as candidate genes in premature ovarian failure. Fertil Steril. 2006; 86(4): 1009-12. doi: 10.1016/j.fertnstert.2006.02.017.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rah H., Jeon Y.J., Ko J.J., et al. Association of inhibin a gene promoter polymorphisms with risk of idiopathic primary ovarian insufficiency in Korean women. Maturitas. 2014; 77(2): 163-7. doi: 10.1016/j.maturitas.2013.10.015.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>M’Rabet N., Moffat R., Helbing S., Kaech A., Zhang H., de Geyter C. The CC-allee of the pvull polymorphic variant in intron 1 of the a-estrogen receptor gene is significanlty more prevalent amoung infertile woman at risk of premature aging. Fertil Steri. 2012; 98(4): 965-72. e1-5. doi: 10.1016/j.fertnstert.2012.05.048.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Cordts E., Santos A., Peluso C., Bianco B., Barbosa C., Christofolini D. Risk of premature ovarian failure is associated with the PvuII polymorphism at estrogen receptor gene ESR1. J Assist Reprod Genet. 2012; 29: 1421-1425. doi: 10.1007/s10815-012-9884-x.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Richards J.S., Russell D.L., Ochsner S., et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res. 2002; 57(1): 195-200. doi: 10.1210/rp.57.1.195</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hong X., Luense L.J., McGinnis L.K., et al. Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology. 2008; 149(12): 6207-12. doi: 10.1210/en.2008-0294.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Lei L., Jin S., Gonzalez G., et al. The regulatory role of Dicer in folliculogenesis in mice. Mol Cell Endocrinol. 2010; 315(1): 63-73. doi: 10.1016/j.mce.2009.09.021</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Otsuka M., Zheng M., Hayashi M., et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest. 2008; 118(5): 1944-54. doi: 10.1172/jci33680</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yao N., Lu C.L., Zhao J.J., et al. A network of miRNAs expressed in the ovary are regulated by FSH. Front Biosci 2009; 14: 3239-45. doi: 10.2741/3447</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Yao G., Yin M., Lian J., et al. MicroRNA-224 is involved in transforming growth factor-P-mediated mouse granulosa cell proliferation and granulosa cell function Ьу targeting Smad4. Mol Endocrinol. 2010; 24(3): 540-551. doi: 10.1210/me.2009-0432</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Fiedler S.D., Carletti M.Z., Hong X., et al. MicroRNA expression within periovulatory mural granulosa cells. Biology Reproduction. 2008; 79: 1030-37. doi: 10.1095/biolreprod.108.069690</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Yao G., Liang M., Liang N., et al. MicroRNA-224 is involved in the regulation of mouse cumulus expansion Ьу targeting Ptx3. Elsevier Science. 2014; 382 (1): 244-53. DOI 10.1016/j.mce.2013.10.014</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Hayes E., Kushnir V., Ma X., et al. Intra-cellular mechanism of Anti-Müllerian hormone (AMH) in regulation of follicular development. Elsevier Moll Cel Endocrinol. 2016; 463: 56-65. doi: 10.1016/j.mce.2016.05.019</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Xu S., Linher-Melville K., Yang B.B., et al. Micro-RNA378 (miR-378) regulates ovarian estradiol production Ьу targeting aromatase. Endocrinology. 2011; 152(10): 3941-3951. doi: 10.1210/en.2011-1147</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Toms D., Xu S., Pan B., et al. Progesterone receptor expression in granulosa cells is suppressed Ьу microRNA-378-3p. Elsevier Science. 2016; 399: 95-102. doi: 10.1016/j.mce.2014.07.022</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Yin M., Lu M., Yao G., et al. Transactivation of microRNA-383 Ьу steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells Ьу targeting RBMS1. Mol Endocrinol. 2012; 26(7): 1129-43. doi: 10.1210/ me.2011-1341</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Zhang Q., Sun H., Jiang Y., et al. MicroRNA-181a suppresses mouse granulosa cell proliferation Ьу targeting activin receptor IIA. PLoS ONE. 2013; 8(3): e59667. doi: 10.1371/journal.pone.0059667</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Yan G., Zhang L., Fang T., et al. MicroRNA-145 suppresses mouse granulosa cell proliferation Ьу targeting activin receptor IB. FEBS Lett. 2012; 586(19): 3263-3270. doi: 10.1016/j.febslet.2012.06.048.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Yang S., Wang S., Luo A., et al. Expression patterns and regulatory functions of microRNAs during the initiation of primordial follicle development in the neonatal mouse ovary. Biol Reprod. 2013; 89(5): 126. doi: 10.1095/biolreprod.113.107730.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Carletti M.Z., Fiedler S.D., Christenson L.K. MicroRNA 21 Wocks apoptosis in mouse periovulatory granulosa cells. Biol Reprod. 2010; 83(2): 286-95. doi: 10.1095/biolreprod.109.081448</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Du X., Zhang L., Li X., et al. TGF-в signaling controls FSHR signaling-reduced ovarian granulosa cell apoptosis through the SMAD4/miR-143 axis. Cell Death Dis. 2016; 7(11): e2476. doi: 10.1038/cddis.2016.379</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Zhang J., Ji X., Zhou D. et al. MiR-143 is critical for the formation of primordial follicles in mice. Frontiers in Bioscience. 2013; 18: 588-97. doi:10.2741/4122</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Wang C., Li D., Zhang S., et al. MicroRNA-125a-5p induces mouse granulosa cell apoptosis Ьу targeting signal transducer and activator of transcription 3. Wolter Kluwer. 2016; 23(1): 100-7. doi: 10.1097/GME.0000000000000507</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Nie M., Yu S., Peng S., et al. miR-23a and miR-27a promote human granulosa cell apoptosis Ьу targeting SMAD5. Biol Reprod. 2015; 93(4): 98. doi: 10.1095/biolreprod.115.130690.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Lin F., Li R., Pan Z.X., et al. miR-26b promotes granulosa cell apoptosis Ьу targeting ATM during follicular atresia in porcine ovary. PLoS ONE. 2012; 7(6): e38640. doi: 10.1371/journal.pone.0038640</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Chen X., Xie M., Liu D., et al. Downregulation of microRNA146a inhibits ovarian granulosa cell apoptosis Ьу simultaneously targeting interleukin1 receptorassociated kinase and tumor necrosis factor receptorassociated factor 6. Mol Med Rep. 2015; 12 (4): 5155-62. doi: 10.3892/mmr.2015.4036.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Cho S.H., An H.J., Kim K.A., et al. Single nucleotide polymorphisms at miR-146a/196a2 and their primary ovarian insufficiency-related target gene regulation in granulosa cells. Public Library of Science. 2017; 12(8): e0183479. doi: 10.1371/journal.pone.0183479.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Sang Q., Yao Z., Wang H., et al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab 2013; 98(7): 3068-79. doi: 10.1210/jc.2013-1715.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Feng R., Sang Q., Zhu Y., et al. MiRNA-320 in the human follicular fluid is associated with embryo quality in vivo and affects mouse embryonic development in vitro. Sci Rep. 2015; 5: 8689. doi: 10.1038/srep08689.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Liang M., Yao G., Yin M., et al. Transcriptional cooperation between p53 and NF-kB p65 regulates microRNA-224 transcription in mouse ovarian granulosa cells. Mol Cell Endocrinol. 2013; 370(1-2): 119-29. doi: 10.1016/j.mce.2013.02.014</mixed-citation></ref></ref-list></back></article>
